Share Email Print

Proceedings Paper

comparison of fluorescence guidance systems for ICG & IRDye800 imaging (Conference Presentation)

Paper Abstract

Fluorescence guidance systems are used for different indications, and the relevant range of concentrations and the relevant dye used varies considerably for human clinical trials. Most systems are designed for high concentration ICG imaging, where 0.1 mg/kg is injected IV and perfusion is imaged, yet other applications such as delayed uptake (or second temporal window) ICG imaging can have tissue concentrations an order of magnitude or more below this. Additionally, IRDye800 is used in both antibody imaging and small protein imaging in clinical trials, but injected doses vary from therapeutic to microdose levels. In this study, the sensitivity to both perfusion dose and microdose ranges were tested for ICG and IRDye800CW, using the Spy Elite system (Stryker) and the Solaris (Perkin Elmer). The sensitivity to ICG was significantly different and the sensitivity to IRDye800 was also different but with opposite choice of the optimal system. The concentrations tested ranged from 0.1 mg/kg down to 0.1 ug/kg. The signal to background limited the sensitivity in both cases, and the ambient light effects were significantly different in the two systems. The in vivo testing in lymphatic and vascular transport was assessed to determine limits to detection for vessel size.

Paper Details

Date Published: 4 March 2019
Proc. SPIE 10862, Molecular-Guided Surgery: Molecules, Devices, and Applications V, 108620F (4 March 2019); doi: 10.1117/12.2511487
Show Author Affiliations
Jason R. Gunn, Dartmouth College (United States)
Alberto J. Ruiz, Dartmouth College (United States)
Hira Shahzad Sardar, Dartmouth College (United States)
Kimberley S Samkoe, Dartmouth College (United States)
Brian W. Pogue, Dartmouth College (United States)

Published in SPIE Proceedings Vol. 10862:
Molecular-Guided Surgery: Molecules, Devices, and Applications V
Brian W. Pogue; Sylvain Gioux, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?